Novelix Pharmaceuticals Share Price

    BSE
    37.4
    +1.78 (5.56%)
    NOVELIX • 30 Jun, 2025 | 03:30 PM
    BUY

    1Y Annualised Return

    88.07%

    3Y Annualised Return

    65.19%

    5Y Annualised Return

    75.27%

    The current prices are delayed, login or Open Demat Account for live prices.

    Novelix Pharmaceuticals Stock Performance

    1W Return21.47
    1Y Return97.47
    Today's Low37.4
    Prev. Close35.62
    Mkt Cap (Cr.)93.31
    1M Return33.86
    3Y Return367.50
    52-Week High37.4
    Open37.40
    PE Ratio0.00
    6M Return54.87
    Today's High37.4
    52-Week Low18.94
    Face Value10

    Novelix Pharmaceuticals Company background

    Founded in: 1994
    Trimurthi Limited was formerly incorporated on December 13, 1994 with the name Trimurthi Securities Ltd. The name of the Company thereafter got changed from Trimurthi Securities Ltd to Trimurthi Drugs Pharmaceuticals Ltd. In September 2006, as per the Scheme of Arrangement, the erstwhile Trimurthi Drugs Pharmaceuticals Ltd amalgamated with the Company. Also, the name of the Company was changed to Trimurthi Drugs Pharmaceuticals Ltd and again to Trimurthi Limited in May, 2016.Initially, the company was engaged in finance and investments in securities. They ceased their operations due to the high volatility in the markets and voluntarily got deregistered as NonBanking financial company. Thereafter, the company explored the possibilities of entering into pharmaceutical and drug industry by way of diversification.In November 2009, the Company received NSEN ISO 9001:2008 / ISO 9001:2008 for marketing and distribution of pharmaceutical products from Kvalitet Veritas Quality Assurance. They had been appointed as Authorized Distributors on all India level for Livewell Food products and ABLE, Pharma, in the Salon District of Himachal Pradesh.During the year 201011, the Company started their first Pharmacy Retail Outlet in Himayath Nagar, Hyderabad. Also, they started their second retail outlet at Inderbagh, Sultan Bazar, Hyderabad. The Company with its full capacity commenced the business operations in food industry business through its wholly owned subsidiary in 2018.The Company started their operations in State of West Bengal. Also, they started marketing of their products in Assam and with that they marked their presence in the eastern part of India.

    As of 30 Jun, 2025, Novelix Pharmaceuticals share price is ₹37.4. The stock opened at ₹37.4 and had closed at ₹35.6 the previous day. During today’s trading session, Novelix Pharmaceuticals share price moved between ₹37.40 and ₹37.40, with an average price for the day of ₹37.40. Over the last 52 weeks, the stock has recorded a low of ₹18.94 and a high of ₹37.40. In terms of performance, Novelix Pharmaceuticals share price has increased by 54.9% over the past six months and has increased by 88.07% over the last year.

    Read More
    Novelix Pharmaceuticals SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years

    Total Investment of ₹65,00,000

    Would have become ₹1,04,34,339 (+60.53%)

    Daily SIP of 25,000 would have become 1,04,34,339 in 1 year with a gain of 39,34,339 (+60.53%)

    View details of Market Depth

    Novelix Pharmaceuticals Fundamental

    Market Cap (in crs)

    93.31

    Face Value

    10

    Turnover (in lacs)

    2.27

    Key Metrics

    Qtr Change %
    New 52W High today
    40.6
    Dividend yield 1yr %
    0

    Novelix Pharmaceuticals Key Financials

    View more

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    Novelix Pharmaceuticals Quarterly Revenue
    Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
    1.24 Cr
    1.36 Cr
    0.69 Cr
    1.11 Cr
    2.46 Cr
    Novelix Pharmaceuticals Yearly Revenue
    Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    9.16 Cr
    9.59 Cr
    10.85 Cr
    10.84 Cr
    10.71 Cr
    9.35 Cr
    Novelix Pharmaceuticals Quarterly Net Profit/Loss
    Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
    -0.14 Cr
    -0.11 Cr
    -1.6 Cr
    -0.7 Cr
    0.35 Cr
    Novelix Pharmaceuticals Yearly Net Profit/Loss
    Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    -2.11 Cr
    -3.74 Cr
    -0.26 Cr
    -0.15 Cr
    -0.35 Cr
    0.03 Cr

    Top Mutual Fund Invested in Novelix Pharmaceuticals

    Promoter
    66.6%
    Public
    33.4%
    Promoter
    66.6%
    Public
    33.4%
    Promoter
    66.6%
    Public
    33.4%
    Promoter
    66.5%
    Public
    33.5%
    Promoter
    66.9%
    Public
    33.1%
    Promoter
    66.9%
    Public
    33.1%

    Novelix Pharmaceuticals Technical Analysis

    Moving Averages Analysis
    37.4
    Current Price
    Bullish Moving Averages
    16
    Bearish Moving Averages
    0
    5Day EMA
    34.40
    10Day EMA
    32.30
    12Day EMA
    31.70
    20Day EMA
    29.90
    26Day EMA
    28.90
    50Day EMA
    25.80
    100Day EMA
    21.60
    200Day EMA
    17.30
    5Day SMA
    34.00
    10Day SMA
    31.40
    20Day SMA
    29.10
    30Day SMA
    27.70
    50Day SMA
    25.40
    100Day SMA
    19.60
    150Day SMA
    16.70
    200Day SMA
    14.80
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    6082 Rs
    6082 Rs
    Week Rs
    1579 Rs
    1579 Rs
    Month Rs
    null Rs
    null Rs
    37.40
    Pivot
    Resistance
    First Resistance
    37.40
    Second Resistance
    37.40
    Third Resistance
    37.40
    Support
    First Support
    37.40
    Second support
    37.40
    Third Support
    37.40
    Relative Strength Index
    99.95
    Money Flow Index
    100
    MACD
    2.77
    MACD Signal
    1.99
    Average True Range
    0.67
    Average Directional Index
    98.22
    Rate of Change (21)
    47.53
    Rate of Change (125)
    246.62

    Novelix Pharmaceuticals Latest News

    30 JUN 2025 | Monday

    Novelix Pharmaceuticals Ltd - 536565 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

    30 JUN 2025 | Monday

    Novelix Pharmaceuticals Ltd - 536565 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

    25 JUN 2025 | Wednesday

    Novelix Pharmaceuticals Ltd - 536565 - Closure of Trading Window

    View More

    Novelix Pharmaceuticals Share Price FAQs

    You can easily buy Novelix Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Novelix Pharmaceuticals share price is ₹37.4 and ₹18.94 as of 30/6/2025.

    Please be aware that Novelix Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    820.35
    +14.95 (+1.86%)
    1,500.60
    -14.80 (-0.98%)
    2,001.50
    -13.40 (-0.67%)
    1,601.80
    -6.20 (-0.39%)
    3,462.00
    +20.90 (+0.61%)
    Top Gainers
    6,217.50
    +198.00 (+3.29%)
    820.35
    +14.95 (+1.86%)
    421.50
    +7.00 (+1.69%)
    872.10
    +14.40 (+1.68%)
    326.75
    +3.30 (+1.02%)
    Top Losers
    1,098.90
    -25.40 (-2.26%)
    1,199.20
    -25.90 (-2.11%)
    2,163.50
    -44.40 (-2.01%)
    4,237.10
    -83.20 (-1.93%)
    12,400.00
    -242.00 (-1.91%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -